Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 5,591 | 4,693 | 2,704 | 6,596 | 17,943 |
| Cost of Goods | 1,348 | 1,310 | 336 | N/A | N/A |
| Gross Profit | 4,243 | 3,383 | 2,368 | 5,071 | 17,943 |
| Operating Expenses | 38,504 | 47,081 | 44,915 | 45,537 | 34,711 |
| Operating Income | -33,913 | -43,388 | -42,211 | -38,941 | -16,768 |
| Interest Expense | 3,495 | 3,156 | 3,066 | 2,610 | 1,124 |
| Other Income | 661 | -3,398 | -2,615 | -513 | 222 |
| Pre-tax Income | -36,747 | -49,942 | -47,892 | -42,064 | -17,670 |
| Net Income Continuous | -36,747 | -49,942 | -47,892 | -42,064 | -17,670 |
| Net Income | $-36,747 | $-49,942 | $-47,892 | $-42,064 | $-17,670 |
| EPS Basic Total Ops | -1.37 | -1.87 | -1.80 | -1.61 | -0.68 |
| EPS Basic Continuous Ops | -1.37 | -1.87 | -1.80 | -1.61 | -0.68 |
| EPS Diluted Total Ops | -1.37 | -1.87 | -1.80 | -1.61 | -0.68 |
| EPS Diluted Continuous Ops | -1.37 | -1.87 | -1.80 | -1.61 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -1.37 | -1.87 | -1.80 | -1.61 | -0.68 |
| EBITDA(a) | $-32,789 | $-42,238 | $-41,139 | $-38,015 | $-16,224 |